Detalles de la búsqueda
1.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071508
2.
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study.
Rheumatology (Oxford)
; 63(1): 93-102, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052534
3.
Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study.
Rheumatology (Oxford)
; 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452297
4.
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 62(1): 77-88, 2022 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416949
5.
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
Rheumatology (Oxford)
; 60(SI): SI59-SI67, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369663
6.
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Lupus
; 30(5): 752-761, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497306
7.
Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.
J Clin Med
; 10(17)2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34501290
Resultados
1 -
7
de 7
1
Próxima >
>>